A subnormal peak cortisol response to stimulation testing does not predict a subnormal cortisol production rate.
BACKGROUND
The decision to commence lifelong glucocorticoid replacement therapy is often based on a cortisol stimulation test. We investigated the relationship between the peak cortisol response to insulin-induced hypoglycemia and daily cortisol production rate (CPR) to ascertain whether provocative tests are accurate in indicating the need to initiate lifelong glucocorticoid replacement.


METHODS
Ten patients (five male; mean age, 44 +/- 13 yr) with pituitary disease and with demonstrably suboptimal peak cortisol response (350-500 nmol/liter) to insulin-induced hypoglycemia, underwent CPR measurement by isotope dilution using gas chromatography-mass spectrometry and 24-h urinary free cortisol (UFC).


RESULTS
The median baseline and peak cortisol attained with hypoglycemia were 284 (164-323) and 473.5 (366-494) nmol/liter, respectively. A strong positive correlation was seen between peak stimulated cortisol and CPR (adjusted for body surface area) (r = 0.75; P = 0.02), and in all patients CPR [4.6 (2.9-15.1) mg/d x m(2)] was within the reference range (2.1-12 mg/d x m(2)) or elevated (one patient). A wide range was found for 24-h UFC [116.5 (20.5-265.9) nmol/liter] in this group of patients, and this parameter lacked significant correlation with either serum cortisol concentration or CPR.


CONCLUSIONS
This is the first study to demonstrate a significant correlation between CPR and peak cortisol values during hypoglycemic challenge. An inadequate cortisol response to hypoglycemia suggests the need for glucocorticoid cover at times of stress, but these data indicate that a suboptimal peak cortisol does not equate to a low CPR and should not be an automatic indication for lifelong glucocorticoid replacement therapy. UFC bears no relation to serum cortisol or CPR and is therefore unhelpful in assessment of such patients.
Paisley
A N
AN
Department of Endocrinology, Christie Hospital, Manchester M20 4BX, United Kingdom.
Rowles
S V
SV
Brandon
D
D
Trainer
P J
PJ
D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D005260:Female; D008401:Gas Chromatography-Mass Spectrometry; D020249:Hormone Replacement Therapy; D006801:Humans; D006854:Hydrocortisone / Q000096:biosynthesis* / Q000097:blood*; D007003:Hypoglycemia / Q000097:blood / Q000139:chemically induced; D007004:Hypoglycemic Agents; D007328:Insulin; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D010900:Pituitary Diseases / Q000097:blood* / Q000175:diagnosis
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D006854:Hydrocortisone